MODULE 7: Outpatient Management

Similar documents
MODULE 8B: Management of Group B Dengue with Warning Signs or Dengue with Co-existing Conditions

MANAGEMENT OF DENGUE INFECTION IN ADULTS (Revised 2 nd Edition) QUICK REFERENCE FOR HEALTHCARE PROVIDERS

Case Study 6C. [TQ, 7-months-old infant girl] Dengue Clinical Management. Acknowledgements

KEY MESSAGES. There are three phases in dengue infection-febrile phase, critical phase and recovery (reabsorption) phase.

Pandemic FLU. What you need to know

Human infection with pandemic (H1N1) 2009 virus: updated interim WHO guidance on global surveillance

Dengue Fever & Dengue Shock Syndrome. 07-May-18 PLES / SLCP 1

Methotrexate. About This Drug. Possible Side Effects. Warnings and Precautions

Outpatient dengue management

Fluid balance in the critically ill child with dengue Too much too little? Professor Lucy Lum Universiti Malaya ASMIC Sept

Rotavirus. Children s Ward Macclesfield District General Hospital.

Tacrolimus. Information for patients about using the drug Tacrolimus.

Severe Dengue Infection in ICU. Shirish Prayag MD, FCCM Pune, India

Treatment monitoring protocol for Dimethyl fumarate therapy in active Relapsing Remitting Multiple Sclerosis

for determining dengue severity in Thai patients

Swine flu - information prescription

Fine-tuning Management in Dengue Fever

Department of Pediatrics, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok 10700, Thailand.

Sepsis. Patient Information

Nivolumab. Other Names: Opdivo. About this Drug. Possible Side Effects (More Common) Warnings and Precautions

Direct Oral Anticoagulant (DOAC)Therapy. Important information for patients prescribed: Apixaban, Dabigatran, Edoxaban or Rivaroxaban

There is no specific antiviral drug treatment for CHIK. Symptomatic. treatment is recommended after excluding more serious conditions like malaria,

PACKAGE LEAFLET: INFORMATION FOR THE USER

Hot Topic: H1N1 Flu (Swine Flu)

Paediatric Directorate

Seasonal Influenza in Pregnancy and Puerperium Guideline (GL1086)

Dengue fever. Dr Owen Tsang Princess Margaret Hospital 31 August 2018 ID forum

Thrombosis and Anticoagulation Team. Warfarin. Information for patients, relatives and carers

SEPSIS INFORMATION BOOKLET. A life-threatening condition triggered by infection

The 2009 WHO dengue case classification: Evidence for its development and its application

How to Take Care of a Sick Person

Your guide to taking LENVIMA for hepatocellular carcinoma (HCC), a type of liver cancer

Flu: What You Can Do. Caring for People at Home

Algorithms & Information Sheets

COPING WITH FLU AT HOME

HERNOVIR 200 mg tablets

For the Patient: Rituximab injection Other names: RITUXAN

Prescribing Framework for Methotrexate for Immunosuppression in ADULTS

ABOUT THIS MEDICATION

DENGUE: Seriousness & severity prediction (2017 epidemic) Severine Page BPharm, PhD Public Health Pharmacist DASS - Service de santé publique

What to Do When You Have (or Think You Have) the Flu

FLU VACCINE INFORMATION The FLU JAB

Let s Talk about Diseases That Are Spread by Mosquitos

Epidemiological Characteristics of Clinically- Confirmed Cases of Chikungunya in Teculutan, Guatemala

PACKAGE LEAFLET: INFORMATION FOR THE USER. EASOFEN MAX STRENGTH 400mg FILM-COATED TABLETS. Ibuprofen

Novel oral anticoagulant therapy (NOAC)

INFLUENZA (FLU) Cleaning to Prevent the Flu

Create the Following Chart in your notebook. Fill in as you go through each one.

For the Patient: Cobimetinib tablets Other names: COTELLIC

For the Patient: ULUAVPMTN

Clinical Assessment Tool

Frequently asked questions: Influenza (flu) information for parents. Seasonal influenza 2017/2018

Nilotinib (nil ot' i nib) is a drug that is used to treat some types of cancer. It is a capsule that you take by mouth.

Package leaflet: Information for the patient. Morphine Unimedic 1 mg/ml solution for injection morphine hydrochloride trihydrate

For the Patient: Fludarabine injection Other names: FLUDARA

INTRODUCTION. Dengue is one of the ten leading. Globally 20 million cases/yr. 24,000 deaths/yr. It is important to know the typical and atypical

Influenza. What Is Influenza?

For the Patient: PROTOCOL SMAVTMZ Other Names: Palliative Therapy for Malignant Melanoma with Brain Metastases Using Temozolomide

Etoricoxib STADA 30 mg, 60 mg, 90 mg and 120 mg film-coated tablets , Version V1.2 PUBLIC SUMMARY OF THE RISK MANAGEMENT PLAN

1. Dengue An Overview. Dengue Expert Advisory Group

Are you aged years old?

Are you aged up to 25 years and starting university for the first time?

GUIDELINE FOR THE MANAGEMENT OF

AN OVERVIEW: THE MANAGEMENT OF FEVER IN CHILDREN

An Introduction to Dengue, Zika and Chikungunya Viruses

Sepsis what you need to know. Adult information leaflet

Products available Methotrexate tablets 2.5mg ONLY (Methotrexate tablets 10mg are NOT recommended as per NPSA guidance 5 ).

SEA-CD-277 FREQUENTLY ASKED QUESTIONS ON DENGUE

Revised Recommendations for the Use of Influenza Antiviral Drugs

Dr. May Book-Montellano, FPPS, FPIDSP, FPSMID President Pediatric Infectious Disease Society of the Philippines

Eloxatin Oxaliplatin concentrated solution for injection

Malaria prevention and control

Rational Therapy of Fever in Children: Special Emphasis on Hydrotherapy

Pandemic Influenza A Matter of Time

For the Patient: Ponatinib Other names: ICLUSIG

Capecitabine. Other Names: Xeloda. About This Drug. Possible Side Effects. Warnings and Precautions

For the Patient: Mitoxantrone Other names:

Fluid Management in Dengue Fever and Dengue Haemorrhagic Fever

For the Patient: CAP. Capecitabine. Uses:

Methotrexate for inflammatory bowel disease: what you need to know

NORVASC 5 mg and 10 mg tablets

Lynda Astbury Lead Diabetes Specialist Nurse

Managing Special Circumstances Key Points

PHARMA DYNAMICS CLOPIDOGREL 75 mg PATIENT INFORMATION LEAFLET

Flu Facts. January 2019

ZIKA VIRUS. Causes, Symptoms, Treatment and Prevention

Nursing Process Focus: Patients Receiving Dextran 40 (Gentran 40)

For the Patient: GIAVPG Other Names: First-line palliative chemotherapy for advanced gallbladder and bile duct cancer using Gemcitabine and Cisplatin

Clinical Guidance for 2009 H1N1 Influenza and Seasonal Influenza. Barbara Wallace, MD New York State Department of Health (Updated 10/8/09)

PRONUNCIATION: (met-for-min) COMMON BRAND NAME(S): Riomet

Rituximab: A drug Information Sheet

I M VACCINATING FOR TWO NOW. IT S A LIFESAVER. Pregnant women and their babies are at risk from flu. Protect you and your baby - get your flu vaccine.

Fever in children aged less than 5 years

Ambulatory Emergency Care Pathways. Painless Obstructive Jaundice

Pain relief after caesarean section. Information for patients Royal Hallamshire Hospital, Jessop Wing

Dexamethasone is used to treat cancer. This drug can be given in the vein (IV), by mouth, or as an eye drop.

WHEN SHOULD I WORRY? - Your guide to Coughs, Colds, Earache & Sore Throa Information For:-

Capecitabine and Lapatinib

For the Patient: Alemtuzumab SC injection Other names: MABCAMPATH, CAMPATH

Cyclophosphamide Treatment (To be used in conjunction with the Shared Care Blood Test Monitoring Card)

Transcription:

MODULE 7: Outpatient Management Dengue Clinical Management Acknowledgements This curriculum was developed with technical assistance from the University of Malaya Medical Centre. Materials were contributed by the Ministry of Health, Singapore, the United States Centers for Disease Control and Prevention, and the University of Malaya Medical Centre.

Dengue deaths by age groups 45 40 Dengue deaths by age group, n=80, 2009 N % 35 30 25 32 24 20 15 10 5 10 14 0 <15 yrs 15 - <35 35 - <50 >50 yrs Ministry of Health, Malaysia, 2009

Entering the clinic health seeking behaviour 80 Dengue deaths: first medical attention * 35% 30% 30% Percentage of patients who seek 1st treatment 25% 20% 17% 20% 15% 14% 10% 5% 8% 6% 4% 1% 0% 1 2 3 4 5 6 7 8 DAYS FROM ONSET OF ILLNESS 30% seek treatment on the day 1 of disease onset 67% seek treatment within 3 days of disease onset * Health seeking behaviour will differ by country and by patient demographics such as sex, socioeconomic status, and ethnicity. Ministry of Health, Malaysia, 2009

Dengue deaths: duration between onset of disease and admission * Percentage of patients admitted 30% Dengue illness onset and admission 25% 25% 20% 19% 20% 16% 15% 10% 9% 5% 5% 5% 1% 0% 1 2 3 4 5 6 7 8 DAYS 49% of dengue deaths admitted within 3 days of illness onset * Admission time varies by country and within countries by year, season, system capacity, e.g. limited hospital beds during an epidemic. Ministry of Health, Malaysia, 2009

Duration between admission and death Dengue deaths: duration between admission and death Percentage of patients who died 30% 25% 25% 20% 19% 15% 13% 13% 10% 8% 6% 6% 5% 3% 1% 1% 1% 1% 1% 1% 1% 0% 0 1 2 3 4 5 6 7 8 9 10 11 12 26 33 DAYS 38% of dengue deaths occurred within 24 hours of admission 57% within 48 hours Ministry of Health, Malaysia, 2009

Reality check #1 Dengue patients seek medical attention early in the febrile phase. Why do patients die if they seek treatment early?

Reality checks #2 and #3 In the early febrile phase, it is difficult to recognize dengue and impossible to predict the course of illness. Daily ambulatory assessment in the febrile stage is essential to avoid unnecessary admissions and detect patients developing severe dengue. Comprehensive outpatient management, early detection and management of shock save lives.

General facts of management The Bad News: No curative treatment or vaccine currently available Disease could be fatal (as high as 20% for severe dengue) The Good News: Several good candidate vaccines are in Phase 1, 2 & 3 clinical trials Proper treatment could reduce CFR of severe dengue to <1% * Treatment is simple, inexpensive and very effective in saving lives so long as correct and timely interventions are instituted. Certain things are common: Recognize that a febrile patient could have dengue especially during outbreaks. Disease notification of suspected cases is essential to assist vector control efforts. * Dengue hemorrhagic fever: diagnosis, treatment, prevention and control. 2nd edition. Geneva, World Health Organization, 1997.

How to save lives What are the keys to a good clinical outcome? 1. Early recognition of dengue and differential diagnosis 2. Identification of clinical problems during the different phases of dengue Early recognition of shock 3. A rational approach to case management Outpatient and home management of dengue Inpatient management of dengue Early management of shock

Management of dengue Step 1: History taking Step 2: Clinical examination: 5-in-1 magic touch Step 3: Investigations Step 4: Diagnosis with dengue phase and severity Step 5: Management decision Group A Group B Group C Send home Refer for inhospital management Require emergency treatment and urgent referral DENCO Slide

Outpatient management: Group A Patients who are able to drink enough to pee enough Group A Send home if patient meets all of the following Intake: Getting adequate volume of oral fluids Output: Passing urine at least once every 4 to 6 hours Does not have any warning signs Has stable haematocrit and hemodynamic status Does not have co-existing conditions 1. Give anticipatory guidance before sending home (see patient handout) 1. Follow up daily 2. Do serial CBCs 3. Identify warning signs early

Keys to good home care 1. Bed rest 2. Encourage oral intake What is adequate oral intake? 6 to 8 glasses of fluid for adults and accordingly in children What types of fluid? Milk, coconut water, fruit juice (caution with diabetes patient), oral rehydration solution, barley water, rice water, clear soup Water alone may cause electrolyte imbalance. 3. Manage fever Give paracetamol if fever is higher than 38 C Adult - not more than 4 g per day Child - 10 mg/kg/dose, not more than 4 times a day Tepid (lukewarm water) sponging Do not give ibuprofen or aspirin (or other non-steroidal anti-inflammatory drugs)

Keys to good home care (cont.) 4. Reduce breeding habitats around the home and kill adult mosquitoes 5. Return to hospital IMMEDIATELY if no improvement or warning signs appear Frequent vomiting, unable to drink or scanty urine Severe abdominal pain Severe tiredness, drowsiness, mental confusion or seizures Bleeding: Red spots or patches on the skin Bleeding from nose or gums Vomiting blood Black coloured stools Heavy menstruation or vaginal bleeding Pale, cold or clammy hands and feet Breathing difficulty 13

Mosquito breeding sites around the home Tray under dish rack Credit: WHO

Mosquito breeding sites around the home Roadside gutters Plant pots Ornaments Discarded items Credit: WHO

What should be avoided? Steroids Pearls in home care Non-steroidal anti-inflammatory drugs (NSAIDs), e.g. acetylsalicylic acid (aspirin), mefenamic acid (Ponstan), and diclofenac (Voltaren) tablets, injections or suppositories. Antibiotics unless you suspect patient may have leptospirosis or dual infection Why are steroids contraindicated in dengue? Not recommended by the World Health Organization (WHO) Limited number of studies in children with dengue shock syndrome in 1970s and 1980s Three recent reviews find no evidence of efficacy and recommended not using steroids routinely * No convincing physiological rationale for use Multiple potential side-effects: gastrointestinal bleeding, hyperglycaemia, immunosuppression * Rajapakse S. Trans Royal Soc of Trop Med Hyg(2009) 103: 122; Panpanich et al. Cochrane Database Syst Rev(2006) 19: CD003488; Tam et al. Clin Infect Dis(2012) 55: 1216 16

Outpatient Management: Group B Group B (any of following) Has warning signs Has co-existing condition: Diabetes mellitus Renal failure Pregnancy Infant Elderly Has social circumstances: Living alone Living far away without a reliable means of transport 1. Admit for inpatient care 2. Monitor hemodynamic status frequently 3. Use HCT to guide interventions 4. Use isotonic IV fluids judiciously 5. Correct metabolic acidosis, electrolytes as needed

Emergency management: Group C Group C (any of following) Severe plasma leakage with shock and/or fluid accumulation with respiratory distress Severe bleeding Severe organ impairment: AST or ALT 1000 and/or impaired consciousness Requires emergency treatment and urgent referral

Summary of management of dengue Group A (all of following) Getting adequate volume of oral fluids Passing urine at least once every 4 to 6 hours No warning signs Has stable haematocrit and haemodynamic status Does not have co-existing conditions 1. Give anticipatory guidance before sending home (see patient handout) 2. Follow up daily 3. Do serial CBCs 4. Identify warning signs early Group B (any of following) Has warning signs Has co-existing condition: Diabetes mellitus, renal failure, pregnant, infant or elderly Has social circumstances: Living alone or living far away without a reliable means of transport 1. Admit for inpatient care 2. Monitor hemodynamic status frequently 3. Use HCT to guide interventions 4. Use isotonic IV fluids judiciously 5. Correct metabolic acidosis, electrolytes as needed Group C (any of following) Severe plasma leakage with shock and/or fluid accumulation with respiratory distress Severe bleeding Severe organ impairment: AST or ALT 1000 and/or impaired consciousness Requires emergency treatment and urgent referral

Saving lives with simple steps Lives can be saved with simple steps 1. Successful patient physician clinical encounter* Very sensitive step: Dengue patient feels vulnerable and perhaps fearful Outpatient department, emergency department and general practitioners have only one window of opportunity to form a solid connection with outpatients. Clinical encounters affect trust, patient understanding and follow-up, all vital for a positive clinical outcome. As doctors and nurses we are in control of this step * James T. The Patient-Physician Clinical Encounter. 2007

Ensuring good patient physician relationships How can you form a connection with patients? Listen to the patient s complaints; ask open-ended questions rather than yes no questions. Examples of open-ended questions: Can you tell me about your illness? How does the illness affect you now? What are you most worried about? Do you have any other concerns that I should know about? Conduct a thorough physical examination holding the patient s hand is crucial to making the connection, CCTV-R. Explain the illness and provide advice in a sympathetic way.

Saving lives with simple steps (cont.) 2. Fast-track patient follow-up. 3. Monitor disease progression daily. For every visit: Ask the 3 golden questions: How much oral fluid intake (in the last 12-24 hours)? How much urine output? Other fluid losses? What activities can the patient do? Monitor disease progression: Fever or defervescence? Development of warning signs? Assess hemodynamic state: 5-in-1 magic touch Conduct serial CBCs until patient is out of the critical phase: Decreasing WBC Rising HCT with concurrent rapid fall in platelet count